Pericytes and brain blood flow in Alzheimer's

The Role of Pericytes in Brain Hypoperfusion in Alzheimer's Disease Development

NIH-funded research Medical University of South Carolina · NIH-11285245

This project looks at whether changes in support cells around brain blood vessels (pericytes) and a protein called Fli-1 cause reduced brain blood flow and blood–brain barrier damage in people with Alzheimer's disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMedical University of South Carolina NIH-funded
Lab location1 site (Charleston, United States)
Project IDNIH-11285245 on NIH RePORTER

What this research studies

Researchers will compare brain tissue from people with Alzheimer's and from people without dementia to measure pericyte health and Fli-1 levels. They will grow human brain pericytes in the lab and expose them to Alzheimer-related proteins and inflammatory signals to see how Fli-1 affects cell survival. The team will use antisense oligonucleotide Gapmers to lower Fli-1 in those cells to test whether that prevents pericyte death and related damage. These lab and human-tissue approaches aim to reveal whether protecting pericytes could help preserve brain blood flow in Alzheimer's.

Who could benefit from this research

Good fit: Ideal candidates would include people with Alzheimer's disease or mild cognitive impairment and individuals willing to donate brain tissue or biological samples for research.

Not a fit: People without Alzheimer's or those hoping for an immediate treatment are unlikely to see direct personal benefit from this basic-research project.

Why it matters

Potential benefit: If successful, this work could point to new ways to protect blood vessel support cells, preserve brain blood flow, and slow Alzheimer's-related decline.

How similar studies have performed: Previous lab studies, including the team's preliminary work, found higher Fli-1 in Alzheimer's brain tissue and showed that lowering Fli-1 protected cultured pericytes, but translating these findings into patient therapies remains unproven.

Where this research is happening

Charleston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.